Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 6;13(9):e066182.
doi: 10.1136/bmjopen-2022-066182.

Safety of influenza vaccination during pregnancy: a systematic review

Affiliations

Safety of influenza vaccination during pregnancy: a systematic review

Dianna M Wolfe et al. BMJ Open. .

Abstract

Objective: We conducted a systematic review to evaluate associations between influenza vaccination during pregnancy and adverse birth outcomes and maternal non-obstetric serious adverse events (SAEs), taking into consideration confounding and temporal biases.

Methods: Electronic databases (Ovid MEDLINE ALL, Embase Classic+Embase and the Cochrane Central Register of Controlled Trials) were searched to June 2021 for observational studies assessing associations between influenza vaccination during pregnancy and maternal non-obstetric SAEs and adverse birth outcomes, including preterm birth, spontaneous abortion, stillbirth, small-for-gestational-age birth and congenital anomalies. Studies of live attenuated vaccines, single-arm cohort studies and abstract-only publications were excluded. Records were screened using a liberal accelerated approach initially, followed by a dual independent approach for full-text screening, data extraction and risk of bias assessment. Pairwise meta-analyses were conducted, where two or more studies met methodological criteria for inclusion. The Grading of Recommendations, Assessment, Development and Evaluation approach was used to assess evidence certainty.

Results: Of 9443 records screened, 63 studies were included. Twenty-nine studies (24 cohort and 5 case-control) evaluated seasonal influenza vaccination (trivalent and/or quadrivalent) versus no vaccination and were the focus of our prioritised syntheses; 34 studies of pandemic vaccines (2009 A/H1N1 and others), combinations of pandemic and seasonal vaccines, and seasonal versus seasonal vaccines were also reviewed. Control for confounding and temporal biases was inconsistent across studies, limiting pooling of data. Meta-analyses for preterm birth, spontaneous abortion and small-for-gestational-age birth demonstrated no significant associations with seasonal influenza vaccination. Immortal time bias was observed in a sensitivity analysis of meta-analysing risk-based preterm birth data. In descriptive summaries for stillbirth, congenital anomalies and maternal non-obstetric SAEs, no significant association with increased risk was found in any studies. All evidence was of very low certainty.

Conclusions: Evidence of very low certainty suggests that seasonal influenza vaccination during pregnancy is not associated with adverse birth outcomes or maternal non-obstetric SAEs. Appropriate control of confounding and temporal biases in future studies would improve the evidence base.

Keywords: Epidemiology; IMMUNOLOGY; Infection control; PUBLIC HEALTH.

PubMed Disclaimer

Conflict of interest statement

Competing interests: BH has previously received honoraria from Eversana for methodologic advice related to the conduct of systematic reviews and meta-analysis. All remaining authors have no competing interests to declare.

Figures

Figure 1
Figure 1
Flow of evidence in a systematic review of the safety of influenza vaccination during pregnancy.
Figure 2
Figure 2
Summary of risk of bias assessments by domain of the Newcastle Ottawa Scale for observational studies comparing seasonal influenza vaccine (TIIV and/or QIIV) to no vaccine, when safety outcomes with the lowest risk of bias were included. QIIV, quadrivalent inactivated influenza vaccine; TIIV, trivalent inactivated influenza vaccine
Figure 3
Figure 3
Forest plots of studies reporting adjusted analyses for preterm birth, by timing of vaccine administration.*Denotes outcomes for which meta-analysis could not be conducted. Forest plots for these outcomes illustrate effects reported in studies that were descriptively summarized. Risk of bias was assessed using the 9-point Newcastle-Ottawa Scale. Higher values are associated with lower risk of bias. Numbers followed by plus signs (+) are lower than the actual total numbers included in the meta-analysis due to unreported raw data in one or more studies. aOR, adjusted odds ratio; aRR, adjusted risk ratio; NR, not reported; ROB, risk of bias; TIIV, trivalent inactivated influenza vaccine.
Figure 4
Figure 4
Forest plots of studies reporting adjusted analyses for the prioritised adverse birth outcomes. ITB, immortal time bias; NR, not reported; ROB, risk of bias; TIIV, trivalent inactivated influenza vaccine. Numbers followed by plus signs (+) are lower than the actual total numbers included in the meta-analysis due to unreported raw data in one or more studies.

Similar articles

Cited by

References

    1. Madhi SA, Nunes MC, Cutland CL. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med 2014;371:2340. 10.1056/NEJMc1412050 - DOI - PubMed
    1. World Health Organization . Influenza vaccines: WHO position paper. Weekly Epidemiol Rec 2005:277–88.
    1. on behalf of the National Advisory Committee on Immunization (NACI), Sinilaite A, Young K, et al. . Summary of the National advisory committee on immunization (NACI) seasonal influenza vaccine statement for 2021-2022. CCDR 2021;47:372–80. 10.14745/ccdr.v47i09a04 - DOI - PMC - PubMed
    1. Grohskopf LA, Alyanak E, Ferdinands JM, et al. . Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices, United States, 2021-22 influenza season. MMWR Recomm Rep 2021;70:1–28. 10.15585/mmwr.rr7005a1 - DOI - PMC - PubMed
    1. Rizzo C, Rezza G, Ricciardi W. Strategies in recommending influenza vaccination in Europe and US. Hum Vaccin Immunother 2018;14:693–8. 10.1080/21645515.2017.1367463 - DOI - PMC - PubMed

Publication types

Grants and funding

-